Skip to main content
Heart logoLink to Heart
. 2000 Aug;84(2):189–192. doi: 10.1136/heart.84.2.189

Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease?

G Lloyd 1, N Patel 1, E McGing 1, A Cooper 1, D Brennand-Roper 1, G Jackson 1
PMCID: PMC1760914  PMID: 10908257

Abstract

OBJECTIVE—To determine whether angina in women with established coronary heart disease varies with changes in hormone concentrations during the menstrual cycle.
DESIGN—Subjects were prospectively studied once a week for four weeks.
SETTING—Cardiology outpatient department of tertiary referral centre.
SUBJECTS—Nine premenopausal women, mean (SEM) age 38.89 (2.18) years, with established coronary heart disease, symptomatic angina, and a positive exercise test.
MAIN OUTCOME MEASURE—Myocardial ischaemia as determined by time to 1 mm ST depression during symptom limited exercise testing. Position in the menstrual cycle was established from hormone concentrations.
RESULTS—The early follicular phase, when oestradiol and progesterone concentrations were both low, was associated with the worst exercise performance in terms of time to onset of myocardial ischaemia, at 290 (79) seconds; the best performance (418 (71) seconds) was when oestrogen concentrations were highest in the mid-cycle (p < 0.05). Similar trends were observed in other measured variables. Progesterone concentrations did not influence exercise performance.
CONCLUSIONS—During the menstrual cycle myocardial ischaemia was more easily induced when oestrogen concentrations were low. This may be important for timing the assessment and evaluating treatment in women with coronary heart disease.


Keywords: myocardial ischaemia; exercise testing; oestradiol; progesterone

Full Text

The Full Text of this article is available as a PDF (113.2 KB).

Figure 1  .

Figure 1  

(A) Oestradiol (pmol/l); (B) progesterone (pmol/l); (C) time to 1 mm ST depression (with SEM) for each of the four phases of the menstrual cycle.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett-Connor E., Wilcosky T., Wallace R. B., Heiss G. Resting and exercise electrocardiographic abnormalities associated with sex hormone use in women. The Lipid Research Clinics Program Prevalence Study. Am J Epidemiol. 1986 Jan;123(1):81–88. doi: 10.1093/oxfordjournals.aje.a114226. [DOI] [PubMed] [Google Scholar]
  2. Clark P. I., Glasser S. P., Lyman G. H., Krug-Fite J., Root A. Relation of results of exercise stress tests in young women to phases of the menstrual cycle. Am J Cardiol. 1988 Jan 1;61(1):197–199. doi: 10.1016/0002-9149(88)91334-3. [DOI] [PubMed] [Google Scholar]
  3. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987 Apr 30;316(18):1105–1110. doi: 10.1056/NEJM198704303161801. [DOI] [PubMed] [Google Scholar]
  4. Collins P., Rosano G. M., Sarrel P. M., Ulrich L., Adamopoulos S., Beale C. M., McNeill J. G., Poole-Wilson P. A. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995 Jul 1;92(1):24–30. doi: 10.1161/01.cir.92.1.24. [DOI] [PubMed] [Google Scholar]
  5. Collins P., Shay J., Jiang C., Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 1994 Oct;90(4):1964–1968. doi: 10.1161/01.cir.90.4.1964. [DOI] [PubMed] [Google Scholar]
  6. Greenberg G., Imeson J. D., Thompson S. G., Meade T. W. Blood pressure and the menstrual cycle. Br J Obstet Gynaecol. 1985 Oct;92(10):1010–1014. doi: 10.1111/j.1471-0528.1985.tb02995.x. [DOI] [PubMed] [Google Scholar]
  7. Hanke H., Hanke S., Ickrath O., Lange K., Bruck B., Mück A. O., Seeger H., Zwirner M., Voisard R., Haasis R. Estradiol concentrations in premenopausal women with coronary heart disease. Coron Artery Dis. 1997 Aug-Sep;8(8-9):511–515. [PubMed] [Google Scholar]
  8. Holdright D. R., Sullivan A. K., Wright C. A., Sparrow J. L., Cunningham D., Fox K. M. Acute effect of oestrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease. Eur Heart J. 1995 Nov;16(11):1566–1570. doi: 10.1093/oxfordjournals.eurheartj.a060779. [DOI] [PubMed] [Google Scholar]
  9. Jiang C., Sarrel P. M., Poole-Wilson P. A., Collins P. Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 1992 Jul;263(1 Pt 2):H271–H275. doi: 10.1152/ajpheart.1992.263.1.H271. [DOI] [PubMed] [Google Scholar]
  10. Kharitonov S. A., Logan-Sinclair R. B., Busset C. M., Shinebourne E. A. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J. 1994 Sep;72(3):243–245. doi: 10.1136/hrt.72.3.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lieberman E. H., Gerhard M. D., Uehata A., Walsh B. W., Selwyn A. P., Ganz P., Yeung A. C., Creager M. A. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994 Dec 15;121(12):936–941. doi: 10.7326/0003-4819-121-12-199412150-00005. [DOI] [PubMed] [Google Scholar]
  12. Lomícek M., Proks V., Presl J. Koronární nemoc srdecní s výraznou vazospastickou slozkou vázanou na menstruacní cyklus a její resení. Vnitr Lek. 1995 Oct;41(10):710–712. [PubMed] [Google Scholar]
  13. MacGregor E. A., Chia H., Vohrah R. C., Wilkinson M. Migraine and menstruation: a pilot study. Cephalalgia. 1990 Dec;10(6):305–310. doi: 10.1046/j.1468-2982.1990.1006305.x. [DOI] [PubMed] [Google Scholar]
  14. Manhem K., Jern S. Influence of daily-life activation on pulse rate and blood pressure changes during the menstrual cycle. J Hum Hypertens. 1994 Nov;8(11):851–856. [PubMed] [Google Scholar]
  15. Proudler A. J., Ahmed A. I., Crook D., Fogelman I., Rymer J. M., Stevenson J. C. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet. 1995 Jul 8;346(8967):89–90. doi: 10.1016/s0140-6736(95)92114-1. [DOI] [PubMed] [Google Scholar]
  16. Rosano G. M., Leonardo F., Sarrel P. M., Beale C. M., De Luca F., Collins P. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet. 1996 Mar 23;347(9004):786–788. doi: 10.1016/s0140-6736(96)90867-3. [DOI] [PubMed] [Google Scholar]
  17. Rosano G. M., Patrizi R., Leonardo F., Ponikowski P., Collins P., Sarrel P. M., Chierchia S. L. Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol. 1997 Sep 15;80(6):815–817. doi: 10.1016/s0002-9149(97)00528-6. [DOI] [PubMed] [Google Scholar]
  18. Rosano G. M., Sarrel P. M., Poole-Wilson P. A., Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993 Jul 17;342(8864):133–136. doi: 10.1016/0140-6736(93)91343-k. [DOI] [PubMed] [Google Scholar]
  19. Skobeloff E. M., Spivey W. H., Silverman R., Eskin B. A., Harchelroad F., Alessi T. V. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med. 1996 Sep 9;156(16):1837–1840. [PubMed] [Google Scholar]
  20. Smith S. C., Jr AHA president's letter. Circulation. 1995 Jul 1;92(1):1–1. [PubMed] [Google Scholar]
  21. Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991 Jan;20(1):47–63. doi: 10.1016/0091-7435(91)90006-p. [DOI] [PubMed] [Google Scholar]
  22. Webb C. M., Rosano G. M., Collins P. Oestrogen improves exercise-induced myocardial ischaemia in women. Lancet. 1998 May 23;351(9115):1556–1557. doi: 10.1016/S0140-6736(05)61121-X. [DOI] [PubMed] [Google Scholar]
  23. Zhang F., Ram J. L., Standley P. R., Sowers J. R. 17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol. 1994 Apr;266(4 Pt 1):C975–C980. doi: 10.1152/ajpcell.1994.266.4.C975. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES